Ligand Pharmaceuticals, Inc. (LGND)
318.78
+7.05
(+2.26%)
USD |
NASDAQ |
Oct 28, 16:00
309.09
-9.69
(-3.04%)
After-Hours: 07:35
Ligand Pharmaceuticals Price to Book Value : 6.563 for Oct. 28, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 6.563 |
| October 27, 2026 | 6.418 |
| October 26, 2026 | 6.348 |
| October 23, 2026 | 6.249 |
| October 22, 2026 | 6.338 |
| October 21, 2026 | 6.481 |
| October 20, 2026 | 6.308 |
| October 19, 2026 | 6.121 |
| October 16, 2026 | 6.085 |
| October 15, 2026 | 6.146 |
| October 14, 2026 | 6.074 |
| October 13, 2026 | 6.249 |
| October 12, 2026 | 6.406 |
| October 09, 2026 | 6.214 |
| October 08, 2026 | 6.074 |
| October 07, 2026 | 6.038 |
| October 06, 2026 | 6.114 |
| October 05, 2026 | 6.316 |
| October 02, 2026 | 6.238 |
| October 01, 2026 | 6.233 |
| September 30, 2026 | 6.431 |
| September 29, 2026 | 6.390 |
| September 28, 2026 | 6.467 |
| September 25, 2026 | 6.208 |
| September 24, 2026 | 6.157 |
| Date | Value |
|---|---|
| September 23, 2026 | 6.144 |
| September 22, 2026 | 6.146 |
| September 21, 2026 | 5.972 |
| September 18, 2026 | 5.837 |
| September 17, 2026 | 5.862 |
| September 16, 2026 | 5.666 |
| September 15, 2026 | 5.703 |
| September 14, 2026 | 5.778 |
| September 11, 2026 | 5.857 |
| September 10, 2026 | 5.955 |
| September 09, 2026 | 5.931 |
| September 08, 2026 | 5.947 |
| September 04, 2026 | 5.880 |
| September 03, 2026 | 5.965 |
| September 02, 2026 | 5.907 |
| September 01, 2026 | 5.853 |
| August 31, 2026 | 5.849 |
| August 28, 2026 | 5.775 |
| August 27, 2026 | 5.858 |
| August 26, 2026 | 5.926 |
| August 25, 2026 | 5.800 |
| August 24, 2026 | 5.769 |
| August 21, 2026 | 5.894 |
| August 20, 2026 | 5.917 |
| August 19, 2026 | 5.985 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 8.002 |
| Eli Lilly & Co. | 35.80 |
| Merck & Co., Inc. | 8.297 |
| ANI Pharmaceuticals, Inc. | 2.758 |
| Corcept Therapeutics, Inc. | 13.19 |
Price to Book Value Related Metrics
| PE Ratio | 34.08 |
| PS Ratio | 22.90 |
| Price to Free Cash Flow | 55.53 |
| Price | 318.78 |
| Earnings Yield | 2.93% |
| Market Cap | 6.350B |
| Operating PE Ratio | 66.47 |
| Normalized PE Ratio | 45.30 |